Pfizer Raises 2026 Forecasts as Third-Quarter Results Are Driven by Eliquis, Cancer Drugs
Pfizer raised its 2026 forecasts as Eliquis and cancer drugs drove third-quarter results.
Story updates
05:13:33 PM UTC
SquawkNews
更新版 5-辉瑞上调2026年业绩预期，因艾乐奇和抗癌药物推动第三季度业绩增长 塞西尔·盖甘被任命为新任首席财务官 本季度Eliquis销售额增长25%，达25.2亿美元 Mevrometostat后
05:13:34 PM UTC
SquawkNews
종합 5-화이자, ‘엘리퀴스’와 항암제 호조로 3분기 실적 호조를 보이며 연간 실적 전망치 상향 조정 세실 게간, 신임 CFO로 선임 엘리퀴스 분기 매출, 25% 증가한 25억 2
05:13:44 PM UTC
SquawkNews
UPDATE 5-ファイザー、3四半期好調で26年見通し上方修正 「エリキュース」けん引 セシル・ゲガン氏が新CFOに就任 「エリキュース」の四半期売上高が２５％増の２５億２０００万ドルに メブロメト